Structure

Physi-Chem Properties

Molecular Weight:  940.54
Volume:  951.469
LogP:  5.412
LogD:  3.32
LogS:  -4.772
# Rotatable Bonds:  2
TPSA:  190.15
# H-Bond Aceptor:  13
# H-Bond Donor:  5
# Rings:  13
# Heavy Atoms:  13

MedChem Properties

QED Drug-Likeness Score:  0.229
Synthetic Accessibility Score:  6.068
Fsp3:  0.836
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.292
MDCK Permeability:  2.033694545389153e-05
Pgp-inhibitor:  0.993
Pgp-substrate:  0.885
Human Intestinal Absorption (HIA):  0.235
20% Bioavailability (F20%):  0.946
30% Bioavailability (F30%):  0.34

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.226
Plasma Protein Binding (PPB):  75.1642837524414%
Volume Distribution (VD):  0.631
Pgp-substrate:  9.186824798583984%

ADMET: Metabolism

CYP1A2-inhibitor:  0.001
CYP1A2-substrate:  0.921
CYP2C19-inhibitor:  0.005
CYP2C19-substrate:  0.839
CYP2C9-inhibitor:  0.034
CYP2C9-substrate:  0.003
CYP2D6-inhibitor:  0.002
CYP2D6-substrate:  0.102
CYP3A4-inhibitor:  0.891
CYP3A4-substrate:  0.808

ADMET: Excretion

Clearance (CL):  8.364
Half-life (T1/2):  0.154

ADMET: Toxicity

hERG Blockers:  0.951
Human Hepatotoxicity (H-HT):  0.992
Drug-inuced Liver Injury (DILI):  0.053
AMES Toxicity:  0.01
Rat Oral Acute Toxicity:  0.996
Maximum Recommended Daily Dose:  0.993
Skin Sensitization:  0.091
Carcinogencity:  0.86
Eye Corrosion:  0.003
Eye Irritation:  0.004
Respiratory Toxicity:  0.991

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC475356

Natural Product ID:  NPC475356
Common Name*:   Cephalostatin 18
IUPAC Name:   n.a.
Synonyms:   Cephalostatin 18
Standard InCHIKey:  CVTSMECTODZBQF-FVNBPLPQSA-N
Standard InCHI:  InChI=1S/C55H76N2O11/c1-26-32-14-15-33-30-12-10-28-16-37-39(21-49(28,6)34(30)18-41(60)52(32,33)25-65-54(26)42(61)22-47(3,4)67-54)56-38-17-29-11-13-31-35(50(29,7)46(64-9)45(38)57-37)19-40(59)51(8)36(31)20-44-53(51,63)27(2)55(66-44)43(62)23-48(5,24-58)68-55/h15,20,26-32,34-35,40,42-44,46,58-59,61-63H,10-14,16-19,21-25H2,1-9H3/t26-,27-,28-,29-,30-,31+,32+,34-,35-,40+,42+,43+,44-,46-,48-,49-,50-,51+,52+,53+,54+,55-/m0/s1
SMILES:  CC1C2CC=C3C2(COC14C(CC(O4)(C)C)O)C(=O)CC5C3CCC6C5(CC7=C(C6)N=C8C(C9(C(CCC1C9CC(C2(C1=CC1C2(C(C2(O1)C(CC(O2)(C)CO)O)C)O)C)O)CC8=N7)C)OC)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL504202
PubChem CID:   10533864
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000258] Steroids and steroid derivatives
        • [CHEMONTID:0001194] Oxosteroids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO25585 Cephalodiscus gilchristi Species Cephalodiscidae Eukaryota n.a. n.a. n.a. PMID[21899266]
NPO25585 Cephalodiscus gilchristi Species Cephalodiscidae Eukaryota n.a. n.a. n.a. PMID[22607450]
NPO25585 Cephalodiscus gilchristi Species Cephalodiscidae Eukaryota n.a. n.a. 1990 PMID[26042639]
NPO25585 Cephalodiscus gilchristi Species Cephalodiscidae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT168 Cell Line P388 Mus musculus ED50 = 4.6 nM PMID[491953]
NPT373 Cell Line SK-MEL-5 Homo sapiens GI50 < 0.001 ug.mL-1 PMID[491954]
NPT575 Cell Line KM-20L2 Homo sapiens GI50 < 0.001 ug.mL-1 PMID[491954]
NPT397 Cell Line NCI-H460 Homo sapiens GI50 < 0.001 ug.mL-1 PMID[491954]
NPT376 Cell Line A498 Homo sapiens GI50 < 0.001 ug.mL-1 PMID[491954]
NPT399 Cell Line SF-295 Homo sapiens GI50 < 0.001 ug.mL-1 PMID[491954]
NPT377 Cell Line OVCAR-3 Homo sapiens GI50 < 0.001 ug.mL-1 PMID[491954]
NPT168 Cell Line P388 Mus musculus ED50 = 4.3 10'-3 ug/ml PMID[491954]
NPT83 Cell Line MCF7 Homo sapiens GI50 = 3.3 nM PMID[491955]
NPT395 Cell Line SF-268 Homo sapiens GI50 = 7.8 nM PMID[491955]
NPT397 Cell Line NCI-H460 Homo sapiens GI50 = 2.8 nM PMID[491955]
NPT90 Cell Line DU-145 Homo sapiens GI50 = 20.0 nM PMID[491955]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. GI50 = 21.7 nM PMID[491954]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. GI50 = 3.3 nM PMID[491955]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. GI50 = 3.1 nM PMID[491955]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC475356 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
NPC

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC475356 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
NPD

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data